Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility Study of RT-310 for Treatment of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)

NCT07264205 is registered in ClinicalTrials.gov with Resurge Therapeutics Inc. as lead sponsor.

NCT NCT07264205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07264205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility Study of RT-310 for Treatment of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Lead sponsor
Resurge Therapeutics Inc.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
March 13, 2025
Completion date
June 30, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bph (benign prostatic hyperplasia)